News Focus
News Focus
icon url

doogdilinger

05/10/18 3:09 PM

#34819 RE: Samsa #34817

Yep the key is mgmt. landing a Regabatin partner...regardless of whether or not there's a large upfront payment or not.

Because once the partner's landed then R&D can be completed and speculation on revenue potential can begin.

We all thought we'd have a large Regabatin partner secured by now...but better late than never right cheers!
icon url

bluelucky

05/10/18 3:10 PM

#34820 RE: Samsa #34817

Really curious why they are waiting on this unless partner will not pay for all trial costs. Get the pipeline moving.

They got 50 people working and tons of secret stuff in the hopper - or so they say.

Honestly what the f are the 50 people doing?
icon url

tilator

05/10/18 3:36 PM

#34823 RE: Samsa #34817

They certainly can not count on Generics now so he should be thinking of some other option.



We must not forget ANDAs are the only thing they have right now because both NDAs are still very long way from home. They might even turn to be a disappointment.

ANDAs are ready to be sold and only 2.5M$ income from each of them yearly would prevent further dilution. I'm confident this can be done. Maybe not in USA, but don't forget there is more than that.